3D 打印药品市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00010199
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 175
Buy Now

2019年3D打印药品市场价值为2852万美元,预计2020年至2027年复合年增长率为9.1%,到2027年将达到5703万美元。

 

3D打印药物是通过3D打印技术,以更安全有效的方式为个人定制的药物。这些药物具有单一的多孔结构,很容易在口腔中分散,因此这些高剂量的药物不需要完整吞咽。 3D打印药物背后的主要理念是设计和开发适合个人需求的药物。全球3D打印药物市场是由个性化药物的日益采用等因素推动的。此外,不断增长的研发活动以及吞咽困难的患病率日益增加,预计也将推动预测期内 3D 市场的增长。然而,利用3D打印来开发非法药物限制了市场的增长。不断发展的医疗保健基础设施和人们对药品 3D 打印的认识不断提高为市场的增长创造有利可图的机会。

利润丰厚的区域 3D 打印药品市场



市场洞察

越来越多地采用个性化药物

个性化医疗是一个不断增长的治疗领域,依赖于特定的药物输送和剂量。根据 PMC 发表的一项研究,2005 年 FDA 批准的新分子实体中,个性化药物仅占 5%;而2016年,这一比例已超过25%。此外,在研产品中 42% 的化合物和 73% 的肿瘤学化合物有潜力成为个性化药物。而且,生物制药公司在过去五年中对个性化药物的研发投入几乎翻了一番,预计未来五年投资将增加33%。生物制药研究人员还预测,未来五年内正在开发的个性化药物数量将增加 69%。

3D 打印提供了通过自动控制创建个性化药物系统的可能性。药物剂量,适用于低和高药物浓度。这些优势使制药公司不仅能够提高疗效和依从性,而且还可以通过扩大和占领其他剂型的市场份额来延长其品牌的寿命。通过这种突破性的制造方法及其快速熔化能力,能够克服一些障碍,从而有助于在固体剂量市场上改善患者的治疗效果。例如,FabRx Ltd. 使用其专有的 Printlets 技术完成了世界上第一个人体临床研究,该技术依靠个性化 3D 打印剂型来治疗患有罕见代谢疾病的儿童。此外,该公司于 2020 年 4 月推出了第一台药物 3D 打印机 M3DIMAKER,用于制造个性化药物。因此,需要新的制造系统来制备个性化药物,而 3D 打印在罕见疾病方面的潜在应用是无数。它可以帮助使药物更安全、对儿童更具吸引力,从而推动 3D 打印药物市场的增长。

基于剂型的见解

根据剂型,3D打印药物市场分为片剂、胶囊、多药植入物、纳米颗粒、溶液和其他剂型。 2019年,平板电脑细分市场占据最大市场份额,预计在预测期内将实现市场最高的复合年增长率。目前,市场上的3D打印药物仅以片剂形式出售。然而,其他剂型可能会在未来几年商业化。

3D 打印药物市场(按剂型) 2019年和2027年


基于技术的见解

根据技术,3D打印药品市场细分为喷墨印刷、直写、拉链剂量、热喷墨印刷、熔融沉积成型、粉末床印刷、立体光刻 (SLA) 和半固态挤出 (SSE)。拉链剂量技术领域占据最大的市场份额;此外,预计在预测期内复合年增长率最高。

战略洞察

产品发布和 FDA 批准是公司普遍采用的策略,以扩大其全球足迹并在策略允许的情况下满足不断增长的需求

3D打印药品市场参与者也采取合作策略,这使他们能够扩大全球客户群,同时帮助他们维护自己的品牌。

  ;

3D 打印药物市场 –按剂型

  • 片剂
  • 胶囊
  • 多药植入剂
  • 纳米颗粒
  • 溶液
  • li>
  • 其他

3D 打印药物市场 –按技术

  • 喷墨打印
  • 直写
  • 压缩剂量
  • 热喷墨打印
  • 熔融沉积建模
  • 粉末床打印
  • 立体光刻(SLA)
  • 半固态挤出(SSE)

3D打印药物市场&ndash ;按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲
    • 南非
    • >
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区

公司简介

  • APRECIA PHARMACEUTICALS, LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GLAXOSMITHKLINE PLC。
  • 阿斯利康
  • Tvasta
  • 默克 KGGA
  • Terumo Corporation
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is 3D Printed Drug?

3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.

What are the driving factors for the 3D printed drugs market across the globe?

Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines

Who are the major players in the 3D printing drugs market?

Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.

The List of Companies - 3D Printed Drugs Market

  1. APRECIA PHARMACEUTICALS, LLC
  2. FabRx LTD
  3. Cycle Pharmaceuticals
  4. GLAXOSMITHKLINE PLC.
  5. ASTRAZENECA
  6. Tvasta
  7. Merck KGGA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports